// App-Quantinova.ai

: Recombinant Apoptosis Inhibitor of Macrophage Protein Ameliorates Transplant Ischemia-Reperfusion Injury

Researchers

Presenter

  • J. Y. Lee

Principal Investigators

  • X. Zhang

  • D. Lian

  • A. R. Haig

  • T. Miyazaki

  • L. Gunaratnam

Medical Centers

  • Microbiology and Immunology, Western University, London, ON, Canada

  • Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, ON, Canada

  • Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, ON, Canada

  • Department of Surgery, Western University, London, ON, Canada

  • Center for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan

  • Department of Surgery, Western University, London, ON, Canada

Locations

  • Canada

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Nephrology

  • Pulmonary/Respiratory Diseases

Disease

  • Ischemia-reperfusion injury

  • Tubular injury

  • Coronary Artery Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Nucleoside diphosphate kinase A

  • Creatinine

  • High Mobility Group Box 1

  • Translocator protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved